Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCICigna
FinDog View：Neutral
TMOThermo Fisher Scientific
FinDog View：Bullish
| Metric | CI | TMO |
|---|
| Close | 280.45 | 648.43 |
| Market Cap | $74.1B | $240B |
| 1M | +1.86% | +10.75% |
| P/E (TTM) | 11.7 | 34.4 |
| Forward P/E | 8.9 | 21.8 |
| P/E 5-Yr Percentile | 4 | 65 |
| P/S | 0.3 | 5.2 |
| P/B | 1.8 | 4.6 |
| Dividend Yield | 1.74% | 0.29% |
| Latest Quarter Revenue | $71.7B | $12.0B |
| Revenue YoY | +6.7% | +10.5% |
| Gross Margin | 20.9% | — |
| Latest Quarter EPS | 6.29 | 4.68 |
| Avg Post-Earnings Move | ±2.0% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 3.92% | 2.36% |
| 90-Day Net Insider Buying | −$6.3M | −$38.9M |
CI · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
